Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

leuprorelineacetaat samenstelling overeenkomend met ; leuproreline - poeder en oplosmiddel voor oplossing voor injectie - geen hulpstoffen ; melkzuur(d,l)-glycolzuur copolymeer ; n-methylpyrrolidon

Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

leuprorelineacetaat samenstelling overeenkomend met ; leuproreline - poeder en oplosmiddel voor oplossing voor injectie - geen hulpstoffen ; melkzuur(d,l)-glycolzuur copolymeer ; n-methylpyrrolidon

Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

leuprorelineacetaat 45 mg/stuk samenstelling overeenkomend met ; leuproreline 41,7 mg/stuk - poeder en oplosmiddel voor oplossing voor injectie - geen hulpstoffen ; melkzuur(d,l)-glycolzuur copolymeer ; n-methylpyrrolidon

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - leuprorelin acetate -

Singapore - engelsk - HSA (Health Sciences Authority)

dch auriga singapore - leuprorelin 20.87 mg eqv to leuprorelin acetate - injection, powder, lyophilized, for suspension,extended release - 22.5 mg - leuprorelin 20.87 mg eqv to leuprorelin acetate 22.5 mg

Singapore - engelsk - HSA (Health Sciences Authority)

dch auriga singapore - leuprorelin 41.7 mg eqv leuprorelin acetate - injection, powder, lyophilized, for suspension,extended release - 45mg - leuprorelin 41.7 mg eqv leuprorelin acetate 45mg

Singapore - engelsk - HSA (Health Sciences Authority)

dch auriga singapore - leuprorelin 6.96 mg eqv leuprorelin acetate - injection, powder, lyophilized, for suspension,extended release - 7.5 mg - leuprorelin 6.96 mg eqv leuprorelin acetate 7.5 mg

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - leuprorelin acetate, quantity: 22.5 mg - injection, modified release - excipient ingredients: polyglactin; n-methyl-2-pyrrolidone - bicalutamide,treatment of advanced prostate cancer in combination with lhrh agonist therapy.,leuprorelin,eligard? is indicated for the palliative treatment of advanced prostate cancer.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - leuprorelin acetate, quantity: 7.5 mg - injection, modified release - excipient ingredients: n-methyl-2-pyrrolidone; polyglactin - bicalutamide,treatment of advanced prostate cancer in combination with lhrh agonist therapy.,leuprorelin,eligard? is indicated for the palliative treatment of advanced prostate cancer.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - leuprorelin acetate, quantity: 22.5 mg - injection, modified release - excipient ingredients: n-methyl-2-pyrrolidone; polyglactin - bicalutamide,treatment of advanced prostate cancer in combination with lhrh agonist therapy.,leuprorelin,eligard? is indicated for the palliative treatment of advanced prostate cancer.